📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mutant Calreticulin in the Myeloproliferative Neoplasms. (2020)

First Author: Prins D

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/hs9.0000000000000333

PubMed Identifier: 32382708

Publication URI: http://europepmc.org/abstract/MED/32382708

Type: Journal Article/Review

Volume: 4

Parent Publication: HemaSphere

Issue: 1

ISSN: 2572-9241